More than 20,000 pork producers and ag professionals from throughout the world attended the 29th World Pork Expo, June 7-9, in Des Moines. Presented by the National Pork Producers Council (NPPC), the 2017 Expo hosted more than 1,000 international guests from nearly 40 countries. We spent the days mainly in the media room covering the latest from the pork community. Content has been accumulated in its own Virtual Ag Newsroom at AgNewswire sponsored by Aptimmune Biologics.
This virtual newsroom includes links to photos, audio, and video from the conference. All content posted here is available free of charge for digital or print publication or broadcast. Credit can be given to AgNewsWire.
“World Pork Expo gives producers the opportunity to see and touch the newest products and technologies for their pork businesses,” says Ken Maschhoff, NPPC president and Illinois pork producer. “It’s a place for producers to interact with each other and share ideas. It also gives employees at all levels a chance to learn, deepen their connection to pork production and have some fun.” Interview with Ken Maschhoff, NPPC president
The National Pork Board, with support from the U.S. Department of Agriculture, announced a new program during this year’s expo. The Secure Pork Supply Plan is a voluntary program designed to support American farmers during a foreign animal disease outbreak. The plan is supported by health officials, not only because it will support them during an outbreak, but also because it can help with understanding where the disease is and isn’t. Interview with Patrick Webb, National Pork Board
On opening day of World Pork Expo, Aptimmune Biologics launched the world’s first commercially available mucosal PRRSV vaccine for swine. “Aptimmune has benefited from ground-breaking research conducted at the University of Illinois, The Ohio State University, and several private companies,” said Aptimmune CEO Aaron Gilbertie during a press conference. “We are proud the launch of BARRICADE® validates our collaborative innovation model. We are exceptionally pleased with early customer feedback. In the coming months, we expect to launch additional vaccines formulated with BARRICADE®, including influenza.” Interview with Aptimmune CEO Aaron Gilbertie
All photos from #WPX17 can be viewed and/or downloaded here: 2017 World Pork Expo photos